Stay updated on Safety of SAGE-718 in Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.

Latest updates to the Safety of SAGE-718 in Huntington's Disease Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%
- Check14 days agoChange DetectedThe web page has updated its facility name and location details, specifically clarifying the location as Washington D.C., District of Columbia, United States, 20007, and has added information regarding Huntington's disease and congenital diseases.SummaryDifference1%
- Check21 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check42 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Safety of SAGE-718 in Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.